KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash & Current Investments (2016 - 2025)

Evolent Health has reported Cash & Current Investments over the past 11 years, most recently at $178.0 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $178.0 million for Q4 2025, up 8.86% from a year ago — trailing twelve months through Dec 2025 was $178.0 million (up 8.86% YoY), and the annual figure for FY2025 was $178.0 million, up 8.86%.
  • Cash & Current Investments for Q4 2025 was $178.0 million at Evolent Health, up from $140.4 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for EVH hit a ceiling of $342.0 million in Q4 2021 and a floor of $112.9 million in Q3 2024.
  • Median Cash & Current Investments over the past 5 years was $204.6 million (2022), compared with a mean of $209.1 million.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 136.59% in 2021 and later tumbled 45.64% in 2024.
  • Evolent Health's Cash & Current Investments stood at $342.0 million in 2021, then tumbled by 40.73% to $202.7 million in 2022, then grew by 1.92% to $206.6 million in 2023, then fell by 20.86% to $163.5 million in 2024, then rose by 8.86% to $178.0 million in 2025.
  • The last three reported values for Cash & Current Investments were $178.0 million (Q4 2025), $140.4 million (Q3 2025), and $175.4 million (Q2 2025) per Business Quant data.